NCT04561336View on ClinicalTrials.gov

Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

August 10, 2018

Primary Completion Date

November 14, 2021

Study Completion Date

November 14, 2021

Conditions
Metastatic Colorectal CancerRAS Wild Type
Interventions
DRUG

Avelumab

avelumab in combination with cetuximab

DRUG

Cetuximab

avelumab in combination with cetuximab

Trial Locations (1)

80131

Università della Campania Luigi Vanvitelli, Napoli

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT04561336 - Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter